Measuring proteinuria 12 months into a clinical trial is the best way to predict long-term renal outcomes in lupus nephritis patients, according to re... More »
The risk for developing diabetes mellitus among patients with systemic lupus erythematosus declined significantly with increasing use of hydroxychloro... More »
The findings of a new study challenge the importance of anti–double stranded DNA antibodies as a diagnostic hallmark for lupus.
The assessment of different anti–double stranded DNA (dsDNA) antibody...
Patients with psoriatic arthritis and psoriasis report having a better response to etanercept the earlier they are treated, according to a post hoc analysis of the PRESTA trial.
Patients with...
Maintaining clinical remission with half-dose etanercept is possible for many rheumatoid arthritis patients, according to a single-center, prospective cohort study.
Over 80% of rheumatoid arthritis...
Two years of either triple therapy or treatment with tumor necrosis factor plus methotrexate failed to eliminate joint inflammation on MRI in a subcoh... More »
Eczema in adulthood is directly associated with an increase in incidence of injuries that cause physical limitations, particularly fracture, bone, and... More »
Ustekinumab treatment was associated with new-onset or worsening psoriatic arthritis in a series of seven patients with psoriasis.
The findings, which support previous observations that patients...
Most newly diagnosed psoriatic arthritis patients have an increased risk for cardiovascular disease that is markedly underestimated by the Framingham ... More »
Asian and Hispanic patients with systemic lupus erythematosus have lower all-cause mortality rates than white, black, and Native American patients, ac... More »
